pTR-UF50-BC 载体 (V002560)

我们所展示的质粒图谱主要是从文献和开放数据库中收集而来,主要是为了方便研究工作,其中一小部分质粒进行了质量控制,可供科学家使用。

所有的产品都严格仅供科学研究使用,不能应用于临床试验,包括人体摄入、注射或外用的药理学用途。

确保质粒的关键元件正确,但是我们并不能保证实验结果。页面展示的图谱序列为理论序列,可能与测序结果不一致,请自行比对后确定是否满足要求。(如果测过序,本页面一般会提供下载)

开放数据库中的大多数载体序列都没有被完全测序。如果实际序列与参考序列的相似度超过99%,则将其视为正确。

由于科学研究是在探索未知,具有很大的不确定性,在任何情况下,我们都不承担超出质粒本身的额外经济损失或责任。

载体名称:
pTR-UF50-BC
载体抗性:
Ampicillin
载体长度:
7404 bp
载体类型:
AAV expression vector
复制子:
ori
载体来源:
Marsic D, Govindasamy L, Currlin S, Markusic DM, Tseng YS, Herzog RW, Agbandje-McKenna M, Zolotukhin S.
启动子:
CAG

pTR-UF50-BC 载体图谱

pTR-UF50-BC7404 bp300600900120015001800210024002700300033003600390042004500480051005400570060006300660069007200repeat_regionCMV enhancerchicken beta-actin promoterchimeric intronluciferaseRegion: Furin cleavage sequenceRegion: 2AmAppleBarcodeSV40 poly(A) signalrepeat_regionoriAmpRAmpR promoterf1 ori

质粒操作方法

1. 发货形式:质粒干粉(常温运输,存于-20度,请务必先转化提质粒后使用)

2. 收到质粒干粉后请先5000rpm离心1min,再加入20μl ddH2O溶解质粒;(质粒复测的浓度有时候与标称值差距较大,这可能是因为冻干质粒在管中的位置、复溶效率、测量偏差以及管壁的吸附导致,因此建议先转化提质粒后再使用)

3. 取1支100μl 感受态于冰上解冻10min,加入2μl质粒,再冰浴30min后,42℃热激60s,不要搅动,再冰浴2min;

4. 加入900μl无抗的LB液体培养基,180rpm震荡37℃培养45min (30℃培养1-1.5小时);

5. 6000rpm离心5min,仅留100μl上清液重悬细菌沉淀,并涂布至目标质粒抗性的LB平板上;

6. 将平板倒置37℃培养14h,如果要求是30℃则培养20h; (菌落过多则将质粒稀释后再转化;没有菌落则加入10μl质粒转化;建议不要直接转表达感受态, 要先转克隆感受态,重提质粒后再导入表达感受态);

7. 挑取单菌落至LB液体培养基中,加入对应抗生素,220rpm震荡培养14h,根据实验需要和质粒提取试剂盒说明书提取质粒。

pTR-UF50-BC 载体序列

LOCUS       40924_43843        7404 bp DNA     circular SYN 18-DEC-2018
DEFINITION  AAV expression vector pTR-UF50-BC, complete sequence.
ACCESSION   .
VERSION     .
KEYWORDS    .
SOURCE      synthetic DNA construct
  ORGANISM  synthetic DNA construct
REFERENCE   1  (bases 1 to 7404)
  AUTHORS   Marsic D, Govindasamy L, Currlin S, Markusic DM, Tseng YS, Herzog 
            RW, Agbandje-McKenna M, Zolotukhin S.
  TITLE     Vector design Tour de Force: integrating combinatorial and rational 
            approaches to derive novel adeno-associated virus variants
  JOURNAL   Mol. Ther. 22 (11), 1900-1909 (2014)
  PUBMED    25048217
REFERENCE   2  (bases 1 to 7404)
  AUTHORS   Zolotukhin S.
  TITLE     Direct Submission
  JOURNAL   Submitted (03-DEC-2013) Pediatrics, University of Florida, 2033 
            Mowry Rd, CGRC 235, Gainesville, FL 32610, USA
REFERENCE   3  (bases 1 to 7404)
  TITLE     Direct Submission
REFERENCE   4  (bases 1 to 7404)
  AUTHORS   .
  TITLE     Direct Submission
COMMENT     SGRef: number: 1; type: "Journal Article"; journalName: "Mol. 
            Ther."; date: "2014"; volume: "22"; issue: "11"; pages: "1900-1909"
COMMENT     SGRef: number: 2; type: "Journal Article"; journalName: "Submitted 
            (03-DEC-2013) Pediatrics, University of Florida, 2033 Mowry Rd, CGRC
            235, Gainesville, FL 32610, USA"
COMMENT     SGRef: number: 3; type: "Journal Article"
COMMENT     ##Assembly-Data-START##
            Sequencing Technology :: Sanger dideoxy sequencing 
            ##Assembly-Data-END##
FEATURES             Location/Qualifiers
     source          1..7404
                     /mol_type="other DNA"
                     /organism="synthetic DNA construct"
     repeat_region   1..151
                     /rpt_family="AAV2 ITR"
     enhancer        345..724
                     /label=CMV enhancer
                     /note="human cytomegalovirus immediate early enhancer"
     promoter        726..1003
                     /label=chicken beta-actin promoter
     intron          1004..2022
                     /label=chimeric intron
                     /note="chimera between introns from chicken beta-actin and
                     rabbit beta-globin"
     CDS             2084..3733
                     /label=luciferase
                     /note="firefly luciferase"
     misc_feature    3734..3745
                     /label=Region: Furin cleavage sequence
                     /note="Region: Furin cleavage sequence"
     misc_feature    3746..3817
                     /label=Region: 2A
                     /note="Region: 2A"
     CDS             3752..3817
                     /codon_start=1
                     /product="2A peptide from foot-and-mouth disease virus
                     polyprotein"
                     /label=F2A
                     /note="Eukaryotic ribosomes fail to insert a peptide bond 
                     between the Gly and Pro residues, yielding separate 
                     polypeptides."
                     /translation="VKQTLNFDLLKLAGDVESNPGP"
     CDS             3818..4525
                     /label=mApple
                     /note="photostable monomeric derivative of DsRed (Shaner et
                     al., 2008)"
     misc_feature    4535..4540
                     /label=Barcode
                     /note="Barcode"
     polyA_signal    4559..4680
                     /label=SV40 poly(A) signal
                     /note="SV40 polyadenylation signal"
     repeat_region   4729..4874
                     /rpt_family="AAV2 ITR"
     rep_origin      complement(5116..5704)
                     /direction=LEFT
                     /label=ori
                     /note="high-copy-number ColE1/pMB1/pBR322/pUC origin of 
                     replication"
     CDS             complement(5878..6735)
                     /label=AmpR
                     /note="beta-lactamase"
     promoter        complement(6736..6840)
                     /label=AmpR promoter
     rep_origin      6867..7295
                     /direction=RIGHT
                     /label=f1 ori
                     /note="f1 bacteriophage origin of replication; arrow
                     indicates direction of (+) strand synthesis"